Home » Topics » Disease categories and therapies » Substance use and poisoning

Substance use and poisoning
RSS

Onconova successfully completes first dose cohort of phase I clinical trial of Ex-RAD

Jan. 27, 2009

Cleveland completes dosing of fourth cohort in safety study of Protectan CBLB-502 for ARS

Jan. 21, 2009

Nabi reaches agreement with FDA on SPA for a phase III clinical trial of NicVax

Jan. 5, 2009

Lundbeck initiates phase III clinical trials with nalmefene for alcohol dependence

Dec. 17, 2008

Alkermes initiates phase I ALKS-33 trial in healthy volunteers

Dec. 5, 2008

Alkermes regains U.S. commercialization rights to Vivitrol from Cephalon

Dec. 3, 2008

Aeolus initiates animal study of AEOL-10150 in damage to the lungs due to radiation

Nov. 25, 2008

Novel NMDA receptor modulator shows neuroprotection against ethanol withdrawal, consumption

Nov. 25, 2008

Novel treatment options for iron overloading divulged in recent Xenon patents

Nov. 20, 2008

Nabi reports final results from phase II immunogenicity study of NicVAX

Oct. 31, 2008

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Feb. 11, 2025.
MJFF grant supports Bexorg’s translational biomarker work
BioWorld Science
Bexorg Inc. has been awarded a research grant from The Michael J. Fox Foundation for Parkinson’s Research (MJFF) through the Targets to Therapies initiative to...
SCAN is core circuit affected in Parkinson’s disease
BioWorld Science
Parkinson’s disease (PD) is a neurodegenerative disorder that affects movement, and tremor is one of its signatures. But it is a much more wide-ranging disorder,...
Astellas’ ASP-2246 shows promise in stroke management
BioWorld Science
Astellas Pharma Inc. recently presented data regarding ASP-2246, a drug candidate comprised of an mRNA encoding the transcription factor NeuroD1 encapsulated in...
News in brief
BioWorld Asia
BioWorld Asia briefs for Feb. 10, 2026